I have been running melanotan II for three years and the honest summary is that the effect is smaller than the internet suggests and real.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Vial content, sterility and reconstitution are three separate questions and the certificate answers about one of them.
Where does the human data stop and the extrapolation start?
What is the first thing you would read if you were starting from zero?
How long before you can reasonably say something is or is not doing anything?
I would take the narrow conclusion. Broad ones are more interesting and less true.
Loose evidence is not nothing, but a washout either side is the only reason to trust your own take.
Read the methods section. It is the only part that says whether the conclusion is allowed to exist.